The Dermatochemistry laboratory of the University Louis Pasteur’s Institute of Chemistry (Strasbourg 1) becomes a partner in the integrated European research project Sens-it-iv whose aim is to develop alternative methods to animal testing in the area of allergy.
Even though animal experimentation remains, for the moment, the most reliable way of testing the allergenic potential of a chemical substance, the wish of the European Union is to gradually reduce the number of animals used in toxicity tests. In 1996, a EU Directive on the protection of animals used for experimental purposes prohibits their use when valid, alternative testing methods exist. However, if the REACH -Registration, evaluation and authorisation of chemicals – legislation is instituted, 3000 chemical products marketed in Europe will have to be evaluated for their toxicological properties. (The objective of REACH is to ask the manufacturers to prove that the products they put on the market are harmless). In this context, it is of utmost importance therefore, to develop alternative strategies based on cell or tissue culture or computer modelling.
The objective of the Sens-it-iv project, which brings together 28 universities, institutes, companies and organisations, is to develop alternative in vitro methods that are able to evaluate the allergenic potential of a chemical substance without having to resort to animal testing. The ULP dermatochemistry laboratory, directed by Professor Jean-Pierre Lepoittevin, is the only chemistry laboratory taking part in the Sens-it-iv project. Its role (dedicated mostly to organic chemistry) will be to evaluate the chemical reactivity of different molecules and to study the reaction mechanisms between allergens (foreign substances capable of triggering an allergic reaction in the body) and cutaneous biomolecules (skin proteins). The results from each partnering laboratory will be gathered and pooled together in order to determine the structure and action of each chemical substance using the technique of bioinformatic simulation to ascertain their toxicity without using the animal experimentation model. The development of these alternative research methods concerns both contact allergens and respiratory allergens. Sens-it-iv takes on its full meaning given the increasing incidence of allergies observed in the European population.
Maria Isabel Pellon Zarragoitia | alfa
In focus: Peptides, the “little brothers and sisters” of proteins
12.11.2018 | Technische Universität Berlin
How to produce fluorescent nanoparticles for medical applications in a nuclear reactor
09.11.2018 | Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague)
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.
Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
12.11.2018 | Life Sciences
12.11.2018 | Materials Sciences
12.11.2018 | Physics and Astronomy